VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 60 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $717,297 | -26.2% | 689,709 | 0.0% | 0.22% | +28.7% |
| Q2 2023 | $972,490 | -11.3% | 689,709 | 0.0% | 0.17% | -24.7% |
| Q1 2023 | $1,096,637 | +8.9% | 689,709 | 0.0% | 0.23% | +4.6% |
| Q4 2022 | $1,006,975 | -65.8% | 689,709 | 0.0% | 0.22% | -68.4% |
| Q3 2022 | $2,945,000 | +10.1% | 689,709 | 0.0% | 0.69% | -3.6% |
| Q2 2022 | $2,676,000 | -20.9% | 689,709 | -3.0% | 0.71% | -16.3% |
| Q1 2022 | $3,385,000 | +30.4% | 711,039 | 0.0% | 0.85% | +69.4% |
| Q4 2021 | $2,595,000 | -54.5% | 711,039 | 0.0% | 0.50% | -43.8% |
| Q3 2021 | $5,703,000 | -29.3% | 711,039 | 0.0% | 0.90% | -10.1% |
| Q2 2021 | $8,063,000 | +4.8% | 711,039 | -14.5% | 1.00% | -29.9% |
| Q1 2021 | $7,693,000 | – | 831,625 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $1,120,000 | 0.80% |
| Samsara BioCapital, LLC | 689,709 | $2,676,000 | 0.71% |
| BVF INC/IL | 3,614,662 | $14,025,000 | 0.68% |
| HAMILTON LANE ADVISORS LLC | 71,491 | $277,000 | 0.11% |
| MAI Capital Management | 647,950 | $2,514,000 | 0.05% |
| Laurion Capital Management LP | 698,000 | $2,708,000 | 0.04% |
| Jasper Ridge Partners, L.P. | 92,939 | $361,000 | 0.02% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,500 | $80,000 | 0.02% |
| Ergoteles LLC | 155,562 | $604,000 | 0.02% |
| Clear Harbor Asset Management, LLC | 25,000 | $97,000 | 0.01% |